Symptoms of dyspnoea · stable COPD
1 finding from 1 review
Health‐related quality of life · stable COPD
1 finding from 1 review
Peak Upper Limb Exercise Capacity (Supported) · stable COPD
1 finding from 1 review
Peak Upper Limb Exercise Capacity (Unsupported) · stable COPD
1 finding from 1 review
Endurance Upper Limb Exercise Capacity (Supported) · stable COPD
1 finding from 1 review
Endurance Upper Limb Exercise Capacity (Unsupported) assessed by total number of rings moved in 6 minutes. · stable COPD
1 finding from 1 review
Upper Limb Strength · stable COPD
1 finding from 1 review
Exacerbations · children with asthma
Tailoring asthma treatment using fractional exhaled nitric oxide probably leads to lower number of participants who had ≥ 1 exacerbations over study period… compared with clinical symptoms (moderate certainty).
1 finding from 1 review
Asthma exacerbations · children with asthma
It is very uncertain whether tailoring asthma treatment using fractional exhaled nitric oxide changes number of asthma exacerbations per 52 weeks (exacerbation rate) compared with clinical symptoms (very low certainty).
1 finding from 1 review
ICS dose at final visit · children with asthma
1 finding from 1 review
Exacerbations · adults with asthma
Tailoring asthma treatment using FeNO probably leads to lower number of participants who had ≥ 1 exacerbations over study period compared with clinical symptoms (moderate certainty).
1 finding from 1 review
Annual Exacerbation Rates · adults with asthma
1 finding from 1 review
ICS dose at final visit · adults with asthma
1 finding from 1 review
Intervention not reported
Exacerbations requiring oral corticosteroids 7.3‐month · people with asthma
The intervention showed no clear difference in exacerbations requiring oral corticosteroids 7.3‐month (low certainty).
1 finding from 1 review
Intervention not reported
Exacerbations requiring hospital admission 7.8‐month · people with asthma
The intervention showed no clear difference in exacerbations requiring hospital admission 7.8‐month (moderate certainty).
1 finding from 1 review
Intervention not reported
Asthma control · people with asthma
1 finding from 1 review
Intervention not reported
Serious and non‐serious adverse events · people with asthma
1 finding from 1 review
Intervention not reported
Asthma‐related quality of life (AQLQ)i 9.6‐month · people with asthma
1 finding from 1 review
Intervention not reported
Lung function % predicted trough FEV1 higher = better 7.6‐month · people with asthma
1 finding from 1 review
Intervention not reported
Unscheduled healthcare visits 6.2‐month · people with asthma
It is very uncertain whether the intervention changes unscheduled healthcare visits 6.2‐month (very low certainty).
1 finding from 1 review